We are analyzing https://link.springer.com/article/10.1007/bf02303698.

Title:
Primary gastrointestinal sarcomas: Analysis of prognostic variables | Annals of Surgical Oncology
Description:
Background: Primary gastrointestinal sarcomas are uncommon, and the clinicopathological determinants of survival remain unclear. In order to correlate clinical presentation, pathological assessment, and treatment with outcome, we have analyzed our institution
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Health & Fitness
Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 7,642,828 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don't see any clear sign of profit-making.

While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Link.springer.com might be plotting its profit, but the way they're doing it isn't detectable yet.

Keywords {🔍}

google, scholar, pubmed, cas, surg, article, primary, gastrointestinal, prognostic, sarcomas, cancer, patients, small, resection, surgical, brennan, tumors, factors, sarcoma, cases, hajdu, analysis, survival, leiomyosarcoma, softtissue, privacy, cookies, content, data, access, review, york, oncol, site, publish, search, oncology, casper, presentation, institution, bowel, complete, grade, management, shiu, information, log, journal, research, annals,

Topics {✒️}

month download article/chapter primary colorectal sarcoma related subjects privacy choices/manage cookies full article pdf primary gastrointestinal sarcoma soft-tissue sarcoma surgical oncology aims adult sarcoma admissions primary gastrointestinal sarcomas localized extremity sarcoma european economic area ileocaecal intussusception treated lymph node metastasis phase iii comparison bolus versus infusion recurrent soft-tissue complete surgical excision major prognostic determinant unfavorable prognostic groups smooth muscle tumors conditions privacy policy primary gastrointestinal leiomyosarcoma survival remain unclear investigational adjuvant therapies conlon md & murray soft-tissue sarcomas adverse prognostic factors high-grade tumors factors affecting survival prognostic factor study accepting optional cookies actuarial 5-year survival predominant histological diagnosis significant prognostic factors check access instant access shiu mh journal finder publish surg clin north clinical cancer article annals surgical oncology 2 article conlon article log adult patients admitted correlate clinical presentation prognostic variables unresectable sarcoma gastrointestinal sarcomas

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Primary gastrointestinal sarcomas: Analysis of prognostic variables
         description: Background: Primary gastrointestinal sarcomas are uncommon, and the clinicopathological determinants of survival remain unclear. In order to correlate clinical presentation, pathological assessment, and treatment with outcome, we have analyzed our institution's recent experience with these tumors. Methods: Records of adult patients admitted to our institution between July 1982 and December 1991 were reviewed. Results: During this period, 38 adult patients (>16 years of age) were admitted to our institution with a primary gastrointestinal sarcoma. They accounted for 2% of all adult sarcoma admissions during that period. The study population was composed of 26 men and 12 women. Ages ranged from 29 to 82 years (mean 59). Disease was localized to the primary site in 30 patients (81%). The stomach was the most frequent site of disease (20 cases). The small bowel was affected in nine cases (five duodenum, four jejunum) and the large bowel in nine cases (two colon, seven rectum). Ninety-two percent of patients were symptomatic at presentation. A complete resection was performed in 27 cases, incomplete resection in seven cases, and biopsy only in the remaining three patients. Nine patients received doxorubicin-based chemotherapy. Leiomyosarcoma (n=35) was the predominant histological diagnosis. Twenty-six tumors were classified as high grade (68%) and 12 as low grade (32%). Overall actuarial 5-year survival was 28% (median follow-up 26 months). Weight loss (p=0.02) and pain at presentation (p=0.05) were adverse prognostic factors. Histological grade (p=0.0002), completeness/extent of surgical resection (p=0.005), or a small bowel primary site were significant determinants of overall survival. The resection of contiguous organs did not affect survival if the primary tumor was completely excised (p=0.422). Age, race, sex, presentation (prior surgery), tumor size, or adjuvant therapy were not significant prognostic factors. Recurrence was noted in 44% after complete resection, and mean time to recurrence was 9 months (median 7, range <1–37). Hepatic metastases (42%) and local recurrence (42%) were the predominant sites of initial failure. For patients with a complete resection, grade was the major prognostic determinant (5-year survival: high grade/complete resection 18% vs. low grade/complete resection 72%, p=0.002). Conclusion: The prognosis of gastrointestinal sarcomas is poor. Complete surgical excision is the optimal therapy. However, our results suggest that surgery alone is inadequate for high-grade tumors. We believe that these patients should be considered candidates for investigational adjuvant therapies.
         datePublished:
         dateModified:
         pageStart:26
         pageEnd:31
         sameAs:https://doi.org/10.1007/BF02303698
         keywords:
            Sarcoma
            Gastrointestinal tumors
            Surgical Oncology
            Oncology
            Surgery
         image:
         isPartOf:
            name:Annals of Surgical Oncology
            issn:
               1534-4681
               1068-9265
            volumeNumber:2
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Kevin C. Conlon
               affiliation:
                     name:Memorial Sloan-Kettering Cancer Center
                     address:
                        name:Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ephraim S. Casper
               affiliation:
                     name:Memorial Sloan-Kettering Cancer Center
                     address:
                        name:the Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Murray F. Brennan
               affiliation:
                     name:Memorial Sloan-Kettering Cancer Center
                     address:
                        name:Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Primary gastrointestinal sarcomas: Analysis of prognostic variables
      description: Background: Primary gastrointestinal sarcomas are uncommon, and the clinicopathological determinants of survival remain unclear. In order to correlate clinical presentation, pathological assessment, and treatment with outcome, we have analyzed our institution's recent experience with these tumors. Methods: Records of adult patients admitted to our institution between July 1982 and December 1991 were reviewed. Results: During this period, 38 adult patients (>16 years of age) were admitted to our institution with a primary gastrointestinal sarcoma. They accounted for 2% of all adult sarcoma admissions during that period. The study population was composed of 26 men and 12 women. Ages ranged from 29 to 82 years (mean 59). Disease was localized to the primary site in 30 patients (81%). The stomach was the most frequent site of disease (20 cases). The small bowel was affected in nine cases (five duodenum, four jejunum) and the large bowel in nine cases (two colon, seven rectum). Ninety-two percent of patients were symptomatic at presentation. A complete resection was performed in 27 cases, incomplete resection in seven cases, and biopsy only in the remaining three patients. Nine patients received doxorubicin-based chemotherapy. Leiomyosarcoma (n=35) was the predominant histological diagnosis. Twenty-six tumors were classified as high grade (68%) and 12 as low grade (32%). Overall actuarial 5-year survival was 28% (median follow-up 26 months). Weight loss (p=0.02) and pain at presentation (p=0.05) were adverse prognostic factors. Histological grade (p=0.0002), completeness/extent of surgical resection (p=0.005), or a small bowel primary site were significant determinants of overall survival. The resection of contiguous organs did not affect survival if the primary tumor was completely excised (p=0.422). Age, race, sex, presentation (prior surgery), tumor size, or adjuvant therapy were not significant prognostic factors. Recurrence was noted in 44% after complete resection, and mean time to recurrence was 9 months (median 7, range <1–37). Hepatic metastases (42%) and local recurrence (42%) were the predominant sites of initial failure. For patients with a complete resection, grade was the major prognostic determinant (5-year survival: high grade/complete resection 18% vs. low grade/complete resection 72%, p=0.002). Conclusion: The prognosis of gastrointestinal sarcomas is poor. Complete surgical excision is the optimal therapy. However, our results suggest that surgery alone is inadequate for high-grade tumors. We believe that these patients should be considered candidates for investigational adjuvant therapies.
      datePublished:
      dateModified:
      pageStart:26
      pageEnd:31
      sameAs:https://doi.org/10.1007/BF02303698
      keywords:
         Sarcoma
         Gastrointestinal tumors
         Surgical Oncology
         Oncology
         Surgery
      image:
      isPartOf:
         name:Annals of Surgical Oncology
         issn:
            1534-4681
            1068-9265
         volumeNumber:2
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Kevin C. Conlon
            affiliation:
                  name:Memorial Sloan-Kettering Cancer Center
                  address:
                     name:Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ephraim S. Casper
            affiliation:
                  name:Memorial Sloan-Kettering Cancer Center
                  address:
                     name:the Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Murray F. Brennan
            affiliation:
                  name:Memorial Sloan-Kettering Cancer Center
                  address:
                     name:Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Annals of Surgical Oncology
      issn:
         1534-4681
         1068-9265
      volumeNumber:2
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Memorial Sloan-Kettering Cancer Center
      address:
         name:Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, USA
         type:PostalAddress
      name:Memorial Sloan-Kettering Cancer Center
      address:
         name:the Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York
         type:PostalAddress
      name:Memorial Sloan-Kettering Cancer Center
      address:
         name:Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Kevin C. Conlon
      affiliation:
            name:Memorial Sloan-Kettering Cancer Center
            address:
               name:Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, USA
               type:PostalAddress
            type:Organization
      name:Ephraim S. Casper
      affiliation:
            name:Memorial Sloan-Kettering Cancer Center
            address:
               name:the Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York
               type:PostalAddress
            type:Organization
      name:Murray F. Brennan
      affiliation:
            name:Memorial Sloan-Kettering Cancer Center
            address:
               name:Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, USA
      name:the Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York
      name:Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(85)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.58s.

LINK . SPRINGER . COM {}